The US Patent Office Grants BIOMARK Additional Patent for its LIQUID BIOPSY Technology

biomark-press-release

THE US PATENT OFFICE GRANTS BIOMARK ADDITIONAL PATENT FOR ITS LIQUID BIOPSY TECHNOLOGY Vancouver, British Columbia – (September 20, 2022) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce today that the US […]

Liquid Biopsy – What Is It?

biomark diagnostics liquid biopsy test tubes with dna blood samples

A liquid biopsy is a test that is  performed on a sample of blood taken from a patient. The test analyzes the blood sample and looks for traces of cancer DNA from tumor cells that are often present in the blood.  Multiple blood samples over a period of time allow physicians and doctors to examine […]

BIOMARK’S LIQUID BIOPSY ASSAY LEVERING METABOLOMICS DEMONSTRATES STRONG PERFORMANCE FOR EARLY LUNG CANCER DETECTION

Vancouver, British Columbia – ( March 24th, 2020) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce that the article “A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection” has been published in the peer-reviewed journal Cancers, validating BioMark’s technology to detect early-stage (I/II) non-small cell lung cancer […]

A supramolecular indicator displacement assay for acetyl amantadine

supramolecular indicator displacement assay for acetyl amantadine, a proxy biomarker for spermidine spermine N1-acetyltransferase SSAT activity

A supramolecular indicator displacement assay for acetyl amantadine, a proxy biomarker for spermidine/spermine N1-acetyltransferase (SSAT) activity Introduction Cancer is a leading cause of death worldwide.1 The number of new cancer cases is expected to increase 40% in the next 15 years in Canada due to an aging and growing population.2 Lung cancer is the most […]

A Good Choice for MMJ and Biotech Market Opportunity

Good Choice for MMJ and Biotech Market Opportunity

A Good Choice for MMJ and Biotech Market Opportunity Gaalen Engen, Stockhouse.com Original article: http://www.stockhouse.com/news/newswire/2016/03/03/a-good-choice-for-mmj-and-biotech-market-opportunity For almost fifty years, his was a trusted voice when it came to sports and news. Bill Good, following in the footsteps of his father, “Breathless Bill”, established himself as a national broadcasting icon over a long career which included […]